These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1576039)
21. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
22. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction. Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648 [TBL] [Abstract][Full Text] [Related]
23. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC). Johnson ES; Cregeen RJ Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612 [TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. Anderson JL J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369 [TBL] [Abstract][Full Text] [Related]
26. Role of the nurse in thrombolytic therapy. Albarran J; Kapeluch H Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624 [TBL] [Abstract][Full Text] [Related]
30. Thrombolytic therapy in acute MI. Weighing the risks and benefits. Ro KG; Anderson HV Postgrad Med; 1990 Dec; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035 [TBL] [Abstract][Full Text] [Related]
31. A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1. O'Connor CM; Meese R; Carney R; Smith J; Conn E; Burks J; Hartman C; Roark S; Shadoff N; Heard M J Am Coll Cardiol; 1994 Jan; 23(1):11-8. PubMed ID: 8277068 [TBL] [Abstract][Full Text] [Related]
32. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
33. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Collen D Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781 [TBL] [Abstract][Full Text] [Related]
34. Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction. Hoffmann JJ Eur Heart J; 1990 Aug; 11 Suppl F():29-35. PubMed ID: 2121489 [TBL] [Abstract][Full Text] [Related]
35. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups. Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990 [TBL] [Abstract][Full Text] [Related]